Protagonist Therapeutics, Inc Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
Protagonist Therapeutics, Inc (PTGX) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 900.00 thousand shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-05
- Protagonist Therapeutics, Inc antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-06-30 was 900.00K shares, a 90.53% decline year-over-year.
- Protagonist Therapeutics, Inc antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 200.00K shares, a 97.94% decline year-over-year.
- Protagonist Therapeutics, Inc antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-09-30 was 9.10M shares, a 1.09% decline year-over-year.
- Protagonist Therapeutics, Inc antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-06-30 was 9.50M shares, a 4.04% decline year-over-year.
- Protagonist Therapeutics, Inc antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 9.00M shares, a 210.34% increase from fiscal 2024.
- Protagonist Therapeutics, Inc antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 2.90M shares, a 66.67% decline from fiscal 2023.
- Protagonist Therapeutics, Inc antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 8.70M shares, a 12.12% decline from fiscal 2022.
- Protagonist Therapeutics, Inc antidilutive securities excluded from computation of earnings per share, amount for fiscal 2022 was 9.90M shares, a 7.96% increase from fiscal 2021.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 900.00K shares 10-Q · filed 2026-08-05 | 900.00K shares 10-Q · filed 2026-08-05 | ||||||
| 2026-03-31 | 200.00K shares 10-Q · filed 2026-05-05 | |||||||
| 2025-12-31 | 9.00M shares 10-K · filed 2026-02-25 | |||||||
| 2025-09-30 | 9.10M shares 10-Q · filed 2025-11-06 | 9.10M shares 10-Q · filed 2025-11-06 | ||||||
| 2025-06-30 | 9.50M shares 10-Q · filed 2026-08-05 | 9.50M shares 10-Q · filed 2026-08-05 | ||||||
| 2025-03-31 | 9.70M shares 10-Q · filed 2026-05-05 | |||||||
| 2024-12-31 | 2.90M shares 10-K · filed 2026-02-25 | |||||||
| 2024-09-30 | 9.20M shares 10-Q · filed 2025-11-06 | 3.20M shares 10-Q · filed 2025-11-06 | ||||||
| 2024-06-30 | 9.90M shares 10-Q · filed 2025-08-06 | 3.40M shares 10-Q · filed 2025-08-06 | ||||||
| 2024-03-31 | 4.20M shares 10-Q · filed 2025-05-06 | |||||||
| 2023-12-31 | 8.70M shares 10-K · filed 2026-02-25 | 8.70M shares 10-K · filed 2024-02-27 | ||||||
| 2023-09-30 | 8.90M shares 10-Q · filed 2024-11-07 | 8.90M shares 10-Q · filed 2024-11-07 | 8.86M shares 10-Q · filed 2023-11-02 | |||||
| 2023-06-30 | 11.70M shares 10-Q · filed 2024-08-06 | 11.72M shares 10-Q · filed 2023-08-03 | ||||||
| 2023-03-31 | 12.00M shares 10-Q · filed 2024-05-07 | 12.00M shares 10-Q · filed 2023-05-04 | ||||||
| 2022-12-31 | 9.90M shares 10-K · filed 2025-02-21 | 9.90M shares 10-K · filed 2023-03-15 | ||||||
| 2022-09-30 | 10.17M shares 10-Q · filed 2023-11-02 | |||||||
| 2022-06-30 | 10.58M shares 10-Q · filed 2023-08-03 | |||||||
| 2022-03-31 | 10.29M shares 10-Q · filed 2023-05-04 | |||||||
| 2021-12-31 | 9.17M shares 10-K · filed 2024-02-27 | |||||||
| 2021-09-30 | 9.38M shares 10-Q · filed 2022-11-08 | |||||||
| 2021-06-30 | 9.26M shares 10-Q · filed 2022-08-04 | |||||||
| 2021-03-31 | 9.02M shares 10-Q · filed 2022-05-05 | |||||||
| 2020-12-31 | 7.67M shares 10-K · filed 2023-03-15 | |||||||
| 2020-09-30 | 7.64M shares 10-Q · filed 2021-11-03 | |||||||
| 2020-06-30 | 7.59M shares 10-Q · filed 2021-08-04 | |||||||
| 2020-03-31 | 7.65M shares 10-Q · filed 2021-05-04 | |||||||
| 2019-12-31 | 6.75M shares 10-K · filed 2022-02-28 | |||||||
| 2019-09-30 | 6.79M shares 10-Q · filed 2020-11-04 | |||||||
| 2019-06-30 | 6.94M shares 10-Q · filed 2020-08-06 | |||||||
| 2019-03-31 | 6.99M shares 10-Q · filed 2020-05-07 | |||||||
| 2018-12-31 | 6.40M shares 10-K · filed 2021-03-10 | |||||||
| 2018-09-30 | 6.38M shares 10-Q · filed 2018-11-06 | 6.38M shares 10-Q · filed 2019-11-06 | ||||||
| 2018-06-30 | 3.20M shares 10-Q · filed 2018-08-07 | 3.20M shares 10-Q · filed 2019-08-07 | ||||||
| 2018-03-31 | 3.12M shares 10-Q · filed 2019-05-08 | |||||||
| 2017-12-31 | 2.46M shares 10-K · filed 2020-03-10 | |||||||
| 2017-09-30 | 2.56M shares 10-Q · filed 2018-11-06 | 2.56M shares 10-Q · filed 2018-11-06 | ||||||
| 2017-06-30 | 2.48M shares 10-Q · filed 2018-08-07 | 2.48M shares 10-Q · filed 2018-08-07 | ||||||
| 2017-03-31 | 2.31M shares 10-Q · filed 2018-05-09 | |||||||
| 2016-12-31 | 2.39M shares 10-K · filed 2019-03-12 | |||||||
| 2016-09-30 | 1.50M shares 10-Q · filed 2017-11-07 | 1.50M shares 10-Q · filed 2017-11-07 | ||||||
| 2016-06-30 | 9.89M shares 10-Q · filed 2017-08-08 | 9.89M shares 10-Q · filed 2017-08-08 | ||||||
| 2016-03-31 | 9.50M shares 10-Q · filed 2017-05-10 | |||||||
| 2015-12-31 | 6.43M shares 10-K · filed 2018-03-07 | |||||||
| 2015-09-30 | 6.07M shares 10-Q · filed 2016-11-14 | 6.07M shares 10-Q · filed 2016-11-14 | ||||||
| 2015-06-30 | 3.64M shares 10-Q · filed 2016-09-15 | 3.64M shares 10-Q · filed 2016-09-15 | ||||||
| 2014-12-31 | 3.65M shares 10-K · filed 2017-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |